Lisa E. Wang
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 4
-
- Ovarian cancer diagnosis and treatment 9
- Co-authors
- Amit M. Oza (30 shared papers)Ian F. Tannock (9 shared papers)Monika Karolina Krzyzanowska (9 shared papers)Lillian L. Siu (27 shared papers)Karl Barry Sharpless (1 shared paper)David Lawson Morris (5 shared papers)Mohammad H. Pourgholami (5 shared papers)Margaret M. Kolb (2 shared papers)
- Journals
- Investigational New Drugs (11 papers)International Journal of Gynecological Cancer (7 papers)Clinical Cancer Research (7 papers)Gynecologic Oncology (6 papers)Nature Communications (5 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Lisa E. Wang
160 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 148
- Oncology 1.8k
- Cancer Research 675
- Reproductive Medicine 355
- Pulmonary and Respiratory Medicine 1.0k
- Obstetrics and Gynecology 231
Countries citing papers authored by Lisa E. Wang
This map shows the geographic impact of Lisa E. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Wang more than expected).
Fields of papers citing papers by Lisa E. Wang
This network shows the impact of papers produced by Lisa E. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Wang. The network helps show where Lisa E. Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa E. Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 353 | |
| 2 | 2016 | 213 | |
| 3 | 2009 | 202 | |
| 4 | 2011 | 176 | |
| 5 | 2021 | 164 | |
| 6 | 2014 | 162 | |
| 7 | 2010 | 138 | |
| 8 | 2007 | 136 | |
| 9 | 2010 | 130 | |
| 10 | 2008 | 130 | |
| 11 | 2017 | 125 | |
| 12 | 2019 | 121 | |
| 13 | 1992 | 116 | |
| 14 | 2019 | 116 | |
| 15 | 2001 | 105 | |
| 16 | 2008 | 104 | |
| 17 | 2004 | 103 | |
| 18 | 2005 | 100 | |
| 19 | 2017 | 99 | |
| 20 | 2019 | 98 |
About Lisa E. Wang
Lisa E. Wang is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Hepatology, having authored 167 papers that have together received 6.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Treatment and Pharmacology (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (675 citations), Reproductive Medicine (355 citations), Pulmonary and Respiratory Medicine (1.0k citations) and Obstetrics and Gynecology (231 citations). Lisa E. Wang has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Amit M. Oza, Ian F. Tannock, Monika Karolina Krzyzanowska, Lillian L. Siu, Karl Barry Sharpless, David Lawson Morris, Mohammad H. Pourgholami, Margaret M. Kolb, Eric Xueyu Chen and Malcolm J. Moore. Their work appears in journals such as Investigational New Drugs, International Journal of Gynecological Cancer, Clinical Cancer Research, Gynecologic Oncology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.